Kimberly Novotny - Templeton Dragon Vice President Assistant Secretary
| TDF Fund | USD 8.59 0.12 1.38% |
Mr. Kimberly H. Novotny is a Vice President, Assistant Secretary of the Company. He also serves as Associate General Counsel, Franklin Templeton Investments Vice President and Corporationrationrate Secretary, Fiduciary Trust International of the South Vice President, Templeton Investment Counsel, LLC Assistant Secretary, Franklin Resources, Inc. and officer of 45 of the investment companies in Franklin Templeton Investments.
| Age | 47 |
| Tenure | 11 years |
| Phone | 65 6241 2662 |
| Web | https://www.franklintempleton.com/en-us-retail/investor/products/other-funds/closed-end-fund-detail.page?FundID=581 |
Templeton Dragon Management Performance (%)
The company has Return on Asset of (0.34) % which means that on every $100 spent on assets, it lost $0.34. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 31.3 %, implying that it generated $31.3 on every 100 dollars invested. Templeton Dragon's management efficiency ratios could be used to measure how well Templeton Dragon manages its routine affairs as well as how well it operates its assets and liabilities.Similar Money Managers
| Showing other executives | One Year Return | ||
| Gifford Zimmerman | Nuveen Municipalome | 65 | |
| Charles Royce | Royce Value Closed | 84 | |
| Steven Gray | Templeton Emerging Markets | 66 | |
| Bradford Stone | Flaherty Crumrine Preferred | 60 | |
| Walter Kelly | Nuveen Preferred and | 49 | |
| Andrew Arnott | John Hancock Financial | 49 | |
| Chad Conwell | Flaherty Crumrine Preferred | 47 | |
| Francis Gannon | Royce Value Closed | 52 | |
| Joel Slager | Nuveen Municipalome | 41 | |
| Jon Meissner | Nuveen Municipalome | 48 | |
| Kevin McCarthy | Nuveen Municipalome | 55 | |
| Maureen Gemma | Eaton Vance Tax | 61 | |
| Payson Swaffield | Eaton Vance Tax | 63 | |
| Gifford Zimmerman | Nuveen Preferred and | 65 | |
| Daniel Omstead | Tekla Healthcare Opportunities | 67 | |
| Walter Kelly | Nuveen Municipalome | 49 | |
| Navid Tofigh | Templeton Emerging Markets | ||
| Alison Baur | Templeton Emerging Markets | 57 | |
| Dr MS | Tekla Life Sciences | 71 | |
| Daniel Omstead | Tekla Life Sciences | 67 | |
| Aliya Gordon | Templeton Emerging Markets | 46 | |
Management Performance
| Return On Equity | 31.3 | ||||
| Return On Asset | -0.34 |
Templeton Dragon Closed Leadership Team
Elected by the shareholders, the Templeton Dragon's board of directors comprises two types of representatives: Templeton Dragon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Templeton. The board's role is to monitor Templeton Dragon's management team and ensure that shareholders' interests are well served. Templeton Dragon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Templeton Dragon's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Kubilis, Chief Financial Officer, Chief Accounting Officer, Treasurer | ||
| David Niemiec, Independent Director | ||
| Robert Lim, Vice President — AML Compliance | ||
| Manraj Sekhon, President and Chief Executive Officer - Investment Management | ||
| Matthew Hinkle, Chief Executive Officer - Finance and Administration | ||
| Craig Tyle, Vice President Assistant Secretary | ||
| Larry Thompson, Independent Director | ||
| Steven Gray, Vice President Assistant Secretary | ||
| Aliya Gordon, Vice President Assistant Secretary | ||
| Navid Tofigh, Vice President Assistant Secretary | ||
| Robert Rosselot, Chief Compliance Officer | ||
| Gregory Johnson, Director | ||
| Lori Weber, Vice President Secretary | ||
| Constantine Tseretopoulos, Independent Director | ||
| Edith Holiday, Lead Independent Director | ||
| Harris Ashton, Independent Director | ||
| Rupert Johnson, Chairman of the Board, Vice President | ||
| Breda Beckerle, Interim Chief Compliance Officer | ||
| J Luttig, Independent Director | ||
| Karen Skidmore, Vice President Assistant Secretary | ||
| Kimberly Novotny, Vice President Assistant Secretary | ||
| Robert Wade, Independent Director | ||
| Mary Choksi, Independent Director | ||
| Alison Baur, Vice President Assistant Secretary | ||
| Ann Bates, Independent Director |
Templeton Fund Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right fund is not an easy task. Is Templeton Dragon a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 31.3 | ||||
| Return On Asset | -0.34 | ||||
| Operating Margin | (65.05) % | ||||
| Current Valuation | 268.23 M | ||||
| Shares Outstanding | 33.8 M | ||||
| Shares Owned By Institutions | 70.38 % | ||||
| Number Of Shares Shorted | 41.97 K | ||||
| Price To Earning | 1.01 X | ||||
| Price To Book | 0.36 X | ||||
| Price To Sales | 42.54 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Templeton Fund
Templeton Dragon financial ratios help investors to determine whether Templeton Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Templeton with respect to the benefits of owning Templeton Dragon security.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |